NI-0401 in Active Crohn's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of the study is to assess the safety and tolerability of daily intravenous NI-0401 treatment, compared to matching placebo. And to assess the ability of NI-0401 to modulate the CD3 complex on T-cells.
Epistemonikos ID: 93141e5f67f6dbbfbd62d7112354c353535a8ce2
First added on: May 04, 2024